GENMARK DIAGNOSTICS INC's ticker is GNMK and the CUSIP is 372309104. A total of 107 filers reported holding GENMARK DIAGNOSTICS INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $349,000 | +1.5% | 54,427 | +12.1% | 1.27% | -6.8% |
| Q1 2019 | $344,000 | +115.0% | 48,573 | +47.2% | 1.37% | +32.3% |
| Q4 2018 | $160,000 | -34.2% | 33,001 | 0.0% | 1.03% | -17.6% |
| Q3 2018 | $243,000 | +7.0% | 33,001 | -7.3% | 1.25% | +24.3% |
| Q2 2018 | $227,000 | -0.9% | 35,581 | -15.6% | 1.01% | +4.6% |
| Q1 2018 | $229,000 | -17.3% | 42,158 | +46.4% | 0.96% | -26.1% |
| Q3 2017 | $277,000 | – | 28,800 | – | 1.30% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|